Connect with us

LATEST UPDATES

Government approves Glenmark’s drug febiflu for treatment of corona

Avatar photo

Published

on

In the midst of the fight against the Corona virus, the drug of Glenmark Pharmaceuticals will now be used to treat Corona patients.

  • Corona virus infected patients growing in the country

  • Glenmark Pharmaceuticals drug approved

In the midst of the fight against the Corona virus, the drug of Glenmark Pharmaceuticals will now be used to treat Corona patients. Glenmark Pharmaceuticals has also received its government approval. Patients with mild symptoms of corona can now be given medication from Glenmark Pharmaceuticals.

Glenmark Pharmaceuticals reported that the company has introduced the antiviral drug Favipiravir under the brand name Fabiflu to treat patients suffering from the corona virus. Glenmark has been approved by the Central Drugs Standard Control Organization (CDSCO) on June 19 to manufacture and market fevipiravir or febiflu.

glenmark_062020084034.jpgGot approval

Let us know that the company’s approval has been received at a time when the infection of corona virus in India has gained momentum. Corona virus cases are increasing faster in India than before. The number of corona patients in India has reached close to four lakhs. At the same time, the company said that this medicine will be found on the advice of a doctor.

The company hoped that this drug will help reduce the current pressure on treatment of corona virus patients to a great extent. The company says that this drug has given good results on patients suffering from mild infection of corona virus.

glenmark_062020083848.jpg

Gave good results

According to Glenmark Pharmaceuticals chairman and managing director Glenn Saldanha, in clinical trials, febiflu gave good results on patients with mild symptoms of corona virus. It is a food drug and is a convenient treatment option. The company will work closely with the government and the medical community so that patients in the country can easily get this medicine.